Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
<p>Whole exome sequencing showing mutational status in the parental HN30-P versus HN30-R8 cisplatin resistant cell lines.</p>
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , , , , , , , , , , , , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
| _version_ | 1849927632866508800 |
|---|---|
| author | Abdullah A. Osman (15056323) |
| author2 | Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| author2_role | author author author author author author author author author author author author author author author author author author |
| author_facet | Abdullah A. Osman (15056323) Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| author_role | author |
| dc.creator.none.fl_str_mv | Abdullah A. Osman (15056323) Emre Arslan (15056326) Mason Bartels (15056329) Chieko Michikawa (15056332) Antje Lindemann (15056335) Katarzyna Tomczak (15056338) Wangjie Yu (15056341) Vlad Sandulache (15056344) Wencai Ma (15056347) Li Shen (14959241) Jing Wang (14959256) Anand K. Singh (15056350) Mitchell J. Frederick (14959253) Nakia D. Spencer (15056353) Jeffery Kovacs (15056356) Timothy Heffernan (15056359) William F. Symmans (15056362) Kunal Rai (15056365) Jeffrey N. Myers (15026901) |
| dc.date.none.fl_str_mv | 2025-11-25T13:12:06Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708162 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Dysregulation_and_Epigenetic_Reprogramming_of_NRF2_Signaling_Axis_Promote_Acquisition_of_Cisplatin_Resistance_and_Metastasis_in_Head_and_Neck_Squamous_Cell_Carcinoma/30708162 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |
| dc.title.none.fl_str_mv | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Whole exome sequencing showing mutational status in the parental HN30-P versus HN30-R8 cisplatin resistant cell lines.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_3f6dcad999aacc25ca9f8fc46b18915a |
| identifier_str_mv | 10.1158/1078-0432.30708162 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708162 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell CarcinomaAbdullah A. Osman (15056323)Emre Arslan (15056326)Mason Bartels (15056329)Chieko Michikawa (15056332)Antje Lindemann (15056335)Katarzyna Tomczak (15056338)Wangjie Yu (15056341)Vlad Sandulache (15056344)Wencai Ma (15056347)Li Shen (14959241)Jing Wang (14959256)Anand K. Singh (15056350)Mitchell J. Frederick (14959253)Nakia D. Spencer (15056353)Jeffery Kovacs (15056356)Timothy Heffernan (15056359)William F. Symmans (15056362)Kunal Rai (15056365)Jeffrey N. Myers (15026901)CancerCancer Risk FactorsTumor BiologyMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyDrug ResistanceDrug TargetsEpigeneticsEpigenomicsHead, Neck & Oral CancersPreclinical ModelsProgression, Invasion & MetastasisTumor progressionSmall Molecule Agents<p>Whole exome sequencing showing mutational status in the parental HN30-P versus HN30-R8 cisplatin resistant cell lines.</p>2025-11-25T13:12:06ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708162https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Dysregulation_and_Epigenetic_Reprogramming_of_NRF2_Signaling_Axis_Promote_Acquisition_of_Cisplatin_Resistance_and_Metastasis_in_Head_and_Neck_Squamous_Cell_Carcinoma/30708162CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307081622025-11-25T13:12:06Z |
| spellingShingle | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma Abdullah A. Osman (15056323) Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |
| status_str | publishedVersion |
| title | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_full | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_fullStr | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_full_unstemmed | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_short | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| title_sort | Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma |
| topic | Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Drug Resistance Drug Targets Epigenetics Epigenomics Head, Neck & Oral Cancers Preclinical Models Progression, Invasion & Metastasis Tumor progression Small Molecule Agents |